https://orcid.org/0000-0002-3913-9048
References
- Abouelela ME, Assaf HK, Abdelhamid RA, Elkhyat ES, Sayed AM, Oszako T, Belbahri L, El Zowalaty AE, Abdelkader MSA. 2021. Identification of potential SARS-CoV-2 main protease and spike protein inhibitors from the Genus Aloe: An in silico study for drug development. Molecules. 26(6):1767.
- Alamri MA, Tahir Ul Qamar M, Mirza MU, Bhadane R, Alqahtani SM, Muneer I, Froeyen M, Salo-Ahen OMH. 2020. Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro. J Biomol Struct Dyn. 24:1–13. PMID: 32579061.
- Gil C, Ginex T, Maestro I, et al. 2020. COVID-19: drug targets and potential treatments. J Med Chem. 63(21):12359–12386.
- Hu X, Cai X, Song X, Li C, Zhao J, Luo W, Zhang Q, Ekumi IO, He Z. 2020. Possible SARS-coronavirus 2 inhibitor revealed by simulated molecular docking to viral main protease and host toll-like receptor. Future Virol. doi:10.2217/fvl-2020-0099.
- Li CJ, Zhang LJ, Dezube BJ, Crumpacker CS, Pardee AB. 1993. Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication. Proc Natl Acad Sci USA. 90(5):1839–1842.
- Liu H, Ye F, Sun Q, Liang H, Li C, Li S, Lu R, Huang B, Tan W, Lai L. 2021. Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro. J Enzyme Inhib Med Chem. 36(1):497–503. PMID: 33491508; PMCID: PMC7850424.
- McKee DL, Sternberg A, Stange U, Laufer S, Naujokat C. 2020. Candidate drugs against SARS-CoV-2 and COVID-19. Pharmacol Res. 157:104859 PMID: 32360480; PMCID: PMC7189851.
- Parikesit AA, Nurdiansyah R. 2021. Natural products repurposing of the H5N1-based lead compounds for the most fit inhibitors against 3C-like protease of SARS-CoV-2. J Pharm Pharmacogn Res. 9(5):730–745. http://ippres.com/jppres.
- Ryu YB, Jeong HJ, Kim JH, Kim YM, Park JY, Kim D, Nguyen TT, Park SJ, Chang JS, Park KH, et al. 2010. Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition. Bioorg Med Chem. 18(22):7940–7947. 15
- Sen D, Bhaumik S, Debnath P, Debnath S. 2021. Potentiality of Moringa oleifera against SARS-CoV-2: identified by a rational computer aided drug design method. J Biomol Struct Dyn. 15:1–18.
- Sen D, Debnath P, Debnath B, Bhaumik S, Debnath S. 2020. Identification of potential inhibitors of SARS-CoV-2 main protease and spike receptor from 10 important spices through structure-based virtual screening and molecular dynamic study. J Biomol Struct Dyn. 2020:1–22..,
- Sornpet B, Potha T, Tragoolpua Y, Pringproa K. 2017. Antiviral activity of five Asian medicinal pant crude extracts against highly pathogenic H5N1 avian influenza virus. Asian Pac J Trop Med. 10(9):871–876.
- Tahir Ul Qamar M, Alqahtani SM, Alamri MA, Chen LL. 2020. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J Pharm Anal. 10(4):313–319. PMID: 32296570
- Wang J, Prinz RA, Liu X, Xu X. 2020. In vitro and in vivo antiviral activity of Gingerenone A on Influenza A virus is mediated by targeting janus kinase 2. Viruses. 12(10):1141..
- Yang H, Yang M, Ding Y, Liu Y, Lou Z, Zhou Z, Sun L, Mo L, Ye S, Pang H, et al. 2003. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc Natl Acad Sci USA. 100(23):13190–13195. 2003
- Yoshino R, Yasuo N, Sekijima M. 2020. Identification of key interactions between SARS-CoV-2 main protease and inhibitor drug candidates. Sci Rep. 10(1):12493.
- Zhou Y, Liu H, He M, Wang R, Zeng Q, Wang Y, Ye W, Zhang Q. 2018. A review of the botany, phytochemical, and pharmacological properties of galangal. In: Alexandru Mihai G, Alina Maria H, editors. Handbook of food bioengineering, natural and artificial flavoring agents and food dyes. Cambridge, Massachusetts, United States: Academic Press, p. 351–396. https://doi.org/10.1016/B978-0-12-811518-3.00011-9
- Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, et al. 2020. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 579(7798):270–273.]